Trimethylamine-N-oxide: a potential biomarker and therapeutic target in ischemic stroke
This article reviews the production of TMAO, TMAO’s relationship with different etiological types of ischemic stroke, and the possibility of reducing TMAO levels to improve the prognosis of ischemic stroke.
Source: Frontiers in Neurology - Category: Neurology Source Type: research
More News: Brain | Economy | International Medicine & Public Health | Ischemic Stroke | Neurology | Stroke | Trimethylamine